Cargando…

A Chitosan—Based Liposome Formulation Enhances the In Vitro Wound Healing Efficacy of Substance P Neuropeptide

Currently, there is considerable interest in developing innovative biodegradable nanoformulations for controlled administration of therapeutic proteins and peptides. Substance P (SP) is a neuropeptide of 11 amino acids that belongs to the tachykinins family and it plays an important role in wound he...

Descripción completa

Detalles Bibliográficos
Autores principales: Mengoni, Tamara, Adrian, Manuela, Pereira, Susana, Santos-Carballal, Beatriz, Kaiser, Mathias, Goycoolea, Francisco M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5750662/
https://www.ncbi.nlm.nih.gov/pubmed/29211047
http://dx.doi.org/10.3390/pharmaceutics9040056
_version_ 1783289772429541376
author Mengoni, Tamara
Adrian, Manuela
Pereira, Susana
Santos-Carballal, Beatriz
Kaiser, Mathias
Goycoolea, Francisco M.
author_facet Mengoni, Tamara
Adrian, Manuela
Pereira, Susana
Santos-Carballal, Beatriz
Kaiser, Mathias
Goycoolea, Francisco M.
author_sort Mengoni, Tamara
collection PubMed
description Currently, there is considerable interest in developing innovative biodegradable nanoformulations for controlled administration of therapeutic proteins and peptides. Substance P (SP) is a neuropeptide of 11 amino acids that belongs to the tachykinins family and it plays an important role in wound healing. However, SP is easily degradable in vivo and has a very short half-life, so the use of chitosan-based nanocarriers could enhance its pharmaceutical properties. In light of the above, the aim of this work was to produce and characterize chitosan-coated liposomes loaded with SP (SP-CH-LP) as novel biomaterials with potential application in mucosal wound healing. The loaded system’s biophysical properties were characterized by dynamic light scattering with non-invasive back scattering (DLS-NIBS), mixed mode measurements and phase analysis light scattering (M3-PALS) and high performance liquid chromatography with ultraviolet/visible light detection (HPLC-UV/VIS). Then, the efficacy of the obtained nanoformulations was examined via proof-of-principle experiments using in vitro cell assays. These assays showed an increment on cell motility and proliferation after treatment with free and encapsulated neuropeptides. Additionally, the effect of SP on wound healing was enhanced by the entrapment on CH-LP. Overall, the amenability of chitosan-based nanomaterials to encapsulate peptides and proteins constitutes a promising approach towards potential novel therapies to treat difficult wounds.
format Online
Article
Text
id pubmed-5750662
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-57506622018-01-10 A Chitosan—Based Liposome Formulation Enhances the In Vitro Wound Healing Efficacy of Substance P Neuropeptide Mengoni, Tamara Adrian, Manuela Pereira, Susana Santos-Carballal, Beatriz Kaiser, Mathias Goycoolea, Francisco M. Pharmaceutics Article Currently, there is considerable interest in developing innovative biodegradable nanoformulations for controlled administration of therapeutic proteins and peptides. Substance P (SP) is a neuropeptide of 11 amino acids that belongs to the tachykinins family and it plays an important role in wound healing. However, SP is easily degradable in vivo and has a very short half-life, so the use of chitosan-based nanocarriers could enhance its pharmaceutical properties. In light of the above, the aim of this work was to produce and characterize chitosan-coated liposomes loaded with SP (SP-CH-LP) as novel biomaterials with potential application in mucosal wound healing. The loaded system’s biophysical properties were characterized by dynamic light scattering with non-invasive back scattering (DLS-NIBS), mixed mode measurements and phase analysis light scattering (M3-PALS) and high performance liquid chromatography with ultraviolet/visible light detection (HPLC-UV/VIS). Then, the efficacy of the obtained nanoformulations was examined via proof-of-principle experiments using in vitro cell assays. These assays showed an increment on cell motility and proliferation after treatment with free and encapsulated neuropeptides. Additionally, the effect of SP on wound healing was enhanced by the entrapment on CH-LP. Overall, the amenability of chitosan-based nanomaterials to encapsulate peptides and proteins constitutes a promising approach towards potential novel therapies to treat difficult wounds. MDPI 2017-12-06 /pmc/articles/PMC5750662/ /pubmed/29211047 http://dx.doi.org/10.3390/pharmaceutics9040056 Text en © 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Mengoni, Tamara
Adrian, Manuela
Pereira, Susana
Santos-Carballal, Beatriz
Kaiser, Mathias
Goycoolea, Francisco M.
A Chitosan—Based Liposome Formulation Enhances the In Vitro Wound Healing Efficacy of Substance P Neuropeptide
title A Chitosan—Based Liposome Formulation Enhances the In Vitro Wound Healing Efficacy of Substance P Neuropeptide
title_full A Chitosan—Based Liposome Formulation Enhances the In Vitro Wound Healing Efficacy of Substance P Neuropeptide
title_fullStr A Chitosan—Based Liposome Formulation Enhances the In Vitro Wound Healing Efficacy of Substance P Neuropeptide
title_full_unstemmed A Chitosan—Based Liposome Formulation Enhances the In Vitro Wound Healing Efficacy of Substance P Neuropeptide
title_short A Chitosan—Based Liposome Formulation Enhances the In Vitro Wound Healing Efficacy of Substance P Neuropeptide
title_sort chitosan—based liposome formulation enhances the in vitro wound healing efficacy of substance p neuropeptide
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5750662/
https://www.ncbi.nlm.nih.gov/pubmed/29211047
http://dx.doi.org/10.3390/pharmaceutics9040056
work_keys_str_mv AT mengonitamara achitosanbasedliposomeformulationenhancestheinvitrowoundhealingefficacyofsubstancepneuropeptide
AT adrianmanuela achitosanbasedliposomeformulationenhancestheinvitrowoundhealingefficacyofsubstancepneuropeptide
AT pereirasusana achitosanbasedliposomeformulationenhancestheinvitrowoundhealingefficacyofsubstancepneuropeptide
AT santoscarballalbeatriz achitosanbasedliposomeformulationenhancestheinvitrowoundhealingefficacyofsubstancepneuropeptide
AT kaisermathias achitosanbasedliposomeformulationenhancestheinvitrowoundhealingefficacyofsubstancepneuropeptide
AT goycooleafranciscom achitosanbasedliposomeformulationenhancestheinvitrowoundhealingefficacyofsubstancepneuropeptide
AT mengonitamara chitosanbasedliposomeformulationenhancestheinvitrowoundhealingefficacyofsubstancepneuropeptide
AT adrianmanuela chitosanbasedliposomeformulationenhancestheinvitrowoundhealingefficacyofsubstancepneuropeptide
AT pereirasusana chitosanbasedliposomeformulationenhancestheinvitrowoundhealingefficacyofsubstancepneuropeptide
AT santoscarballalbeatriz chitosanbasedliposomeformulationenhancestheinvitrowoundhealingefficacyofsubstancepneuropeptide
AT kaisermathias chitosanbasedliposomeformulationenhancestheinvitrowoundhealingefficacyofsubstancepneuropeptide
AT goycooleafranciscom chitosanbasedliposomeformulationenhancestheinvitrowoundhealingefficacyofsubstancepneuropeptide